SC 13G 1 dsc13g.htm PETMED EXPRESS, INC. PetMed Express, Inc.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

PetMed Express, Inc.

(Name of issuer)

 

 

Common Stock

(Title of class of securities)

716382106

(CUSIP number)

December 31, 2009

(Date of event which requires filing of this statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


 

CUSIP No. 716382106

 

  1.   

Names of reporting persons.

 

Lord, Abbett & Co. LLC

  2.  

Check the appropriate box if a member of a group (see instructions)

(a)  ¨        (b)  ¨

 

  3.  

SEC use only

 

  4.  

Citizenship or place of organization

 

    Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   5.    

Sole voting power

 

    1,115,756

   6.   

Shared voting power

 

    0

   7.   

Sole dispositive power

 

    1,276,287

   8.   

Shared dispositive power

 

    0

  9.

 

Aggregate amount beneficially owned by each reporting person

 

    1,276,287

10.

 

Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨

 

    N/A

11.

 

Percent of class represented by amount in Row (9)

 

    5.59%

12.

 

Type of reporting person (see instructions)

 

    IA

 

2


Item 1.  

(a)

   Name of Issuer      
     PetMed Express, Inc.      
 

(b)

   Address of Issuer’s Principal Executive Offices      
    

1441 SW 29 Avenue

Pompano Beach, FL 33069

     
Item 2.  

(a)

   Name of Person Filing      
     Lord, Abbett & Co. LLC.      
 

(b)

   Address of Principal Business Office or, if none, Residence      
    

90 Hudson Street

Jersey City, NJ 07302.

     
 

(c)

   Citizenship      
     See No. 4 on page 2.      
 

(d)

   Title of Class of Securities      
     See cover page.      
 

(e)

   CUSIP Number      
     See cover page.      
Item 3.   If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:   
  (a)    ¨    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  (b)    ¨    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  (c)    ¨    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  (d)    ¨    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
  (e)    x    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f)    ¨    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g)    ¨    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
  (h)    ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j)    ¨    A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);
 

(k)

   ¨    Group, in accordance with § 240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:                                         

 

3


Item 4.    Ownership      
   Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.      
   (a)    Amount beneficially owned:      
      See No. 9 on page 2.      
   (b)    Percent of class:      
      See No. 11 on page 2.      
   (c)    Number of shares as to which the person has:      
      (i)    Sole power to vote or to direct the vote      
         See No. 5 on page 2.      
      (ii)    Shared power to vote or to direct the vote      
         See No. 6 on page 2.      
      (iii)    Sole power to dispose or to direct the disposition of      
         See No. 7 on page 2.      
      (iv)    Shared power to dispose or to direct the disposition of      
         See No. 8 on page 2.      
Item 5.    Ownership of Five Percent or Less of a Class   
   If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨.   
   Not applicable.   
Item 6.    Ownership of More than Five Percent on Behalf of Another Person      
   Securities reported on this Schedule 13G as being beneficially owned by Lord, Abbett & Co. LLC are held on behalf on investment advisory clients, which may include investment companies registered under the Investment Company Act, employee benefit plans, pension funds or other institutional clients.   
   Not applicable.      
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
  

Not applicable.

Item 8.    Identification and Classification of Members of the Group      
  

Not applicable.

     
Item 9.    Notice of Dissolution of Group      
  

Not applicable.

     

 

4


Item 10.    Certification      
   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.      

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 12, 2010

Date

/S/    LAWRENCE H. KAPLAN        

Signature

LAWRENCE H. KAPLAN/GENERAL COUNSEL

Name/Title

 

5